ipilimumab,nivolumab
bms
['sclc', 'lcsm,(-blcsm)', 'energy', 'nsclc']
dr herve lena discusses energy-gfpc 06-2015 study results. efficacy of n-i combination vs platinum doublet in elderly #nsclc patients with a benefit of os of 22.6 months vs. 11.8 for ct arm, demonstrates feasibility of studies including elderly #asco22 #lcsm 
LUNGevity Foundation is dedicated to funding lung cancer research and providing support to ALL people affected by lung cancer.